Many studies have shed light on the association between blood coagulation and cancer progression [191, 192]; Therefore, TF-targeted therapies can be effective in reducing tumor growth, angiogenesis, and metastasis in many cancers (Table 3) [59, 60, 189, 190]. This evidence concerns the gene TF and neoplasm.